Search - tctmd.com

Displaying 381 - 400 of 485

Sort: Relevancy | Date

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Evolution of TAVR in Denmark May Have Implications for Other Countries

L.A. McKeown

June 06, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

Presentation

TAVR Compared with SAVR in Low-Risk Patients

Presenter: Stefano Rosato

May 16, 2016

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Todd Neale

April 27, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

Advertisement

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Evolution of TAVR in Denmark May Have Implications for Other Countries

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

TAVR Compared with SAVR in Low-Risk Patients

Italian Registry Cautions Against TAVR in Low-Risk Patients

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

TCTMD’s Top 10 Most Popular Stories for April 2016

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content